RAC 2.86% $1.44 race oncology ltd

Ann: Appendix 2A, page-6

  1. 701 Posts.
    lightbulb Created with Sketch. 119
    @RaceOncology If we ever needed more funds these guys might be worth a llok at


    https://www.prnewswire.com/news-releases/the-leukemia--lymphoma-society-therapy-acceleration-program-lls-tap-announces-five-new-investments-supporting-next-generation-cell-therapies-and-a-novel-immune-checkpoint-inhibitor-301274791.html

    About LLS's Therapy Acceleration Program® (TAP)The Leukemia & Lymphoma Society's Therapy Acceleration Program is a strategic initiative that builds business alliances and collaborations with biotechnology companies and academic researchers to identify potential breakthrough therapies with the ability to change the standard of care. LLS TAP funds late-stage preclinical studies, and proof of concept or registrational clinical trials to help advance therapeutics along the drug development and approval pathway. LLS TAP accepts funding applications on a rolling basis from companies with innovative science that has a high potential to improve patient lives. To learn more, visit www.LLS.org/therapy-acceleration-program.

    Contact:

    Irene Tung
    Senior Manager, Mission Communications
    The Leukemia & Lymphoma Society
    [email protected]
    (718)-414-7910

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.44
Change
0.040(2.86%)
Mkt cap ! $245.3M
Open High Low Value Volume
$1.45 $1.49 $1.41 $101.7K 69.88K

Buyers (Bids)

No. Vol. Price($)
1 9216 $1.44
 

Sellers (Offers)

Price($) Vol. No.
$1.47 7767 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.